Retina

In this Healio Video Perspective from the ASRS meeting, Ashkan M. Abbey, MD, of Texas Retina Associates discusses 36-month real-world data on the Yutiq implant for the treatment of chronic noninfectious uveitis.

A questionnaire found that the majority of retina fellows planned to go into a retina-only private practice.

Eclipse Life Sciences has enrolled and dosed the first patient in the BETTIS-1 phase 2 clinical trial investigating the EC-104 implant for the treatment of diabetic macular edema, according to a press release.

The progression of myopia among school-aged children in China appeared to primarily affect changes in inner retinal thickness over the course of 1 year, according to research.

When managing myopic traction maculopathy, the timing of surgery should be carefully evaluated, avoiding early or delayed intervention, according to a speaker at the American Society of Retina Specialists annual meeting.

Practices should have a plan for disasters and conduct drills to be prepared, according to a speaker at the American Society of Retina Specialists annual meeting.

Intravitreal injections have a large environmental impact, estimated to be around 210 million kg of CO2 equivalent per year in the U.S. alone, according to a presenter at the American Society of Retina Specialists annual meeting.

Wearing gloves for intravitreal injections does not decrease the risk for endophthalmitis but does take up time and has a significant carbon footprint, according to a study.

In this Healio Video Perspective from the ASRS meeting, Ashkan M. Abbey, MD, of Texas Retina Associates discusses data from the DAVIO 2 trial investigating EYP-1901 for the treatment of wet age-related macular degeneration.

Defining intraoperative parameters for vitrectomy may help shed light on the complexity of a case, according to a study presented at the American Society of Retina Specialists meeting.